Drug Packaging, Preservatives, and Microorganisms: An Essential Combination for Maintaining Product Quality
The quality of a pharmaceutical product is determined not only by its active ingredients but also by the packaging system used. Pharmaceutical packaging serves to protect the product from various factors that may compromise its stability, including microbial contamination that can occur during storage and use.
On the other hand, many pharmaceutical products rely on preservatives to inhibit the growth of microorganisms. However, interactions among the drug formulation, preservatives, and drug packaging materials can affect the effectiveness of this protection. Therefore, understanding the relationship between packaging, preservatives, and microorganisms is essential to ensuring that product quality is maintained throughout its shelf life.
Table of content:
- Why Does Drug Packaging Affect Microbial Growth?
- The Relationship Between Packaging, Preservatives, and the Microbiological Safety of Drug Products
Why Does Drug Packaging Affect Microbial Growth?
Microorganisms such as bacteria, molds, and yeasts can pose a threat to pharmaceutical product quality, particularly in liquid formulations or products intended for repeated use. If microbes gain access to a product, they may proliferate and cause changes in its physical and chemical properties.
To prevent such issues, many pharmaceutical products contain antimicrobial preservatives. These preservatives inhibit the growth of microorganisms, helping to ensure that the product remains safe for use during storage and after the package has been opened.
However, the presence of preservatives alone does not always guarantee optimal protection. The effectiveness of a preservative is highly dependent on its compatibility with other materials that come into direct contact with the product, including primary packaging components such as bottles, rubber closures, and seals.
In some cases, packaging materials may interact with preservatives through adsorption or absorption processes. As a result, a portion of the preservative may adhere to the packaging surface or be absorbed into the packaging material, leading to a gradual decrease in its concentration within the product over time.
A reduction in preservative concentration can become a serious concern because the level of protection against microorganisms also declines. If the preservative concentration falls below its effective level, microorganisms that enter the product may grow and cause contamination during storage.
Therefore, evaluating the compatibility of the drug formulation, preservative system, and packaging materials is an important aspect of pharmaceutical product development. Such testing helps ensure that preservatives remain effective, thereby maintaining the product’s quality, safety, and stability throughout its shelf life.
Read also:
The Importance of Preservative Efficacy Testing in Multi Dose Drug
The Relationship Between Packaging, Preservatives, and the Microbiological Safety of Drug Products
Preservatives used in pharmaceutical products are not always stable when they come into contact with different types of packaging materials. Certain preservatives, such as benzalkonium chloride, may interact with materials like polyethylene or polyvinyl chloride, resulting in a reduction of their concentration within the product. To minimize this risk, glass and polypropylene containers are often considered safer alternatives.
A similar phenomenon has been observed with benzyl alcohol and chlorobutanol. These preservatives can be absorbed by certain plastics, silicone tubing, and rubber closures commonly used in pharmaceutical packaging. As preservative levels decline during storage, the product’s ability to inhibit microbial growth may also decrease.
Other preservatives, including phenol and m-cresol, face comparable challenges. Their concentrations may be reduced through interactions with silicone tubing or specific types of rubber stoppers. For this reason, using tightly sealed containers and protecting products from light exposure are important measures for maintaining preservative stability.
Parabens are also known to be absorbed by certain packaging materials, particularly some plastics and silicone tubing. In fact, the tendency of parabens to be absorbed into packaging materials may increase with molecular size or chain length. In contrast, glass containers, polypropylene packaging, and fluoropolymer-based tubing have been shown to better preserve preservative concentrations during storage.
In addition to the type of preservative and packaging material, factors such as pH, preservative concentration, humidity, and storage conditions can also influence the extent of preservative loss. Therefore, careful selection of the combination of drug formulation and packaging materials is essential during product development. This approach helps ensure that preservative levels remain stable, thereby maintaining protection against microbial growth throughout the product’s shelf life.
Protect Product Quality Early
If your drug product uses specific packaging and contains preservatives, make sure both truly support product safety. Packaging, preservatives, and microorganism risks are closely connected in maintaining drug quality during storage and use.
With IML Testing and Research, you can conduct professional product testing to help ensure quality, safety, and product claims are more measurable.
Author: Dherika
Editor: Alphi
References
Amin, A., Dare, M., Sangamwar, A., & Bansal, A.K. (2012). Interaction of Antimicrobial Preservatives with Blow-Fill-Seal Packs: Correlating Sorption with Solubility Parameters. Pharm. Dev. Technol, 17, 614–624.
Stroppel, L., Schultz-Fademrecht, T., Cebulla, M., Blech, M., Marhöfer, R.J., Selzer, P.M., Garidel, P. (2023). Antimicrobial Preservatives for Protein and Peptide Formulations: An Overview. Pharmaceutics, 15, 563.
